APA (7th ed.) Citation

X, Z., EA, A., SE, U., JS, C., LM, C., S, U., . . . RR, A. (2026). Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 32(9), 1632. https://doi.org/10.1158/1078-0432.CCR-25-4043

Chicago Style (17th ed.) Citation

X, Zhu, et al. "Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 32, no. 9 (2026): 1632. https://doi.org/10.1158/1078-0432.CCR-25-4043.

MLA (9th ed.) Citation

X, Zhu, et al. "Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 32, no. 9, 2026, p. 1632, https://doi.org/10.1158/1078-0432.CCR-25-4043.